High altitude pulmonary edema
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
High altitude pulmonary edema (HAPE) is a life-threatening form of non-cardiogenic pulmonary edema that occurs in otherwise healthy mountaineers at altitudes above 2,500 meters (8,202 ft). Some cases have however been reported also at lower altitudes (between 1500 and 2500 m in highly vulnerable subjects), although what makes some people susceptible to HAPE is not currently known. HAPE remains the major cause of death related to high altitude exposure with a high mortality in absence of emergency treatment.
Etiology
The initial insult that causes HAPE is a shortage of oxygen which is caused by the lower air pressure at high altitudes.[1] The mechanisms by which this shortage of oxygen causes HAPE are poorly understood, but two processes are believed to be important:
- Increased pulmonary arterial and capillary pressures (pulmonary hypertension) secondary to hypoxic pulmonary vasoconstriction.[2]
- An idiopathic non-inflammatory increase in the permeability of the vascular endothelium.[3]
Although higher pulmonary arterial pressures are associated with the development of HAPE, the presence of pulmonary hypertension may not in itself be sufficient to explain the development of edema: severe pulmonary hypertension can exist in the absence of clinical HAPE in subjects at high altitude.[4]
Incidence
The incidence of clinical HAPE in unacclimatized travelers exposed to high altitude (~ 4,000 m) appears to be less than 1%. In over 30 years of research experience, the U.S. Army Pike's Peak Research Laboratory, utilizing about 300 sea-level resident volunteers (and more than 100 staff members) rapidly and directly exposed to high altitude, only 3 were evacuated with suspected HAPE.
Predisposing factors
Individual susceptibility to HAPE is difficult to predict. The most reliable risk factor is previous susceptibility to HAPE, and there is likely to be a genetic basis to this condition, perhaps involving the gene for angiotensin converting enzyme (ACE).
Research
In order to help understand the factors that make some individuals susceptible to HAPE, the International HAPE Database was set up in 2004.[5] Individuals who have previously suffered from HAPE can register with this confidential database in order to help researchers study the condition.
Footnotes
- ↑ Kenneth Baillie and Alistair Simpson. Barometric pressure calculator. Apex (Altitude Physiology EXpeditions). Retrieved on 2006-08-10. - Online altitude calculator
- ↑ Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O (Oct 31 1991). "Prevention of high-altitude pulmonary edema by nifedipine.". N Engl J Med 325 (18): 1284-9. PMID 1922223.
- ↑ Swenson E, Maggiorini M, Mongovin S, Gibbs J, Greve I, Mairbäurl H, Bärtsch P (2002). "Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor.". JAMA 287 (17): 2228-35. PMID 11980523.
- ↑ Maggiorini M, Mélot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, Scherrer U, Naeije R (2001). "High-altitude pulmonary edema is initially caused by an increase in capillary pressure.". Circulation 103 (16): 2078-83. PMID 11319198.
- ↑ International HAPE database. Apex (Altitude Physiology EXpeditions). Retrieved on 2006-08-10.
External links
See also
- Acetazolamide, a drug which speeds up acclimatization to high altitudes.
- Pulmonary Edema
- Altitude sickness
- International HAPE database
- High altitude cerebral edema
- HAFE
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

